Rhodococcus equi (Magnusson) Goodfellow and Alderson-质粒载体-ATCC-DSM-CCUG-泰斯拓生物

你好,请登录   免费注册    |    收藏本站
联系电话: 0574-87917803
联系电话: 0574-87917803
Rhodococcus equi (Magnusson) Goodfellow and Alderson
Rhodococcus equi (Magnusson) Goodfellow and Alderson
规格:
货期:
编号:TS145880
品牌:Testobio
产品名称: Rhodococcus equi (Magnusson) Goodfellow and Alderson
商品货号: TS145880
Deposited As: Corynebacterium equi Magnusson
Strain Designations: 13-9
Application:
Degrades levulinic acid
Biosafety Level: 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format: freeze-dried
Disclosure: This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Preceptrol®: no
Type Strain: no
Medium: ATCC® Medium 44: Brain Heart Infusion Agar/Broth
Growth Conditions:
Temperature: 30.0°C
Name of Depositor: Kikkoman Shioyu Co., Ltd.
U.S. Patent Number:
References:

Ueno T, Harada M. Method for removing levulinic acid by microorganisms. US Patent 3,663,368 dated May 16 1972

首页 > 产品中心 > 微生物培养 > 菌株 > null > Rhodococcus equi (Magnusson) Goodfellow and Alderson

Rhodococcus equi (Magnusson) Goodfellow and Alderson

  • 货号: TS145880
  • 好评
有货
  • 品牌 : TESTOBIO
产品名称: Rhodococcus equi (Magnusson) Goodfellow and Alderson
商品货号: TS145880
Deposited As: Corynebacterium equi Magnusson
Strain Designations: 13-9
Application:
Degrades levulinic acid
Biosafety Level: 2

Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country.

Product Format: freeze-dried
Disclosure: This material is cited in a US or other Patent and may not be used to infringe the claims. Depending on the wishes of the Depositor, ATCC may be required to inform the Patent Depositor of the party to which the material was furnished. This material may not have been produced or characterized by ATCC.
Preceptrol®: no
Type Strain: no
Medium: ATCC® Medium 44: Brain Heart Infusion Agar/Broth
Growth Conditions:
Temperature: 30.0°C
Name of Depositor: Kikkoman Shioyu Co., Ltd.
U.S. Patent Number:
References:

Ueno T, Harada M. Method for removing levulinic acid by microorganisms. US Patent 3,663,368 dated May 16 1972

合作单位: